CRISPR-based approaches for studying inborn errors of immunity

Keywords

CRISPR / inborn errors of immunity / neurodevelopmental disorders / NK cells

References

[1] Chinn IK, Orange JS. Immunodeficiency Disorders. Pediatr Rev. 2019; 40: 229-242.

[2] Chinn IK, Chan AY, Chen K, et al. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2020; 145: 46-69.

[3] Li JH, Zhou A, Lee CD, et al. MEF2C regulates NK cell effector functions through control of lipid metabolism. Nat Immunol. 2024;25(5):778-789.

[4] Orange JS. How I manage natural killer cell deficiency. J Clin Immunol. 2020; 40: 13-23.

[5] Riggan L, Hildreth AD, Rolot M, et al. CRISPR-Cas9 ribonucleoprotein-mediated genomic editing in mature primary innate immune cells. Cell Rep. 2020; 31: 107651-107651.

[6] Cooley Coleman JA, Sarasua SM, Boccuto L, Moore HW, Skinner SA, DeLuca JM. Comprehensive investigation of the phenotype of MEF2C-related disorders in human patients: a systematic review. Am J Med Genet A. 2021; 185: 3884-3894.

[7] Cooley Coleman JA, Sarasua SM, Moore HW, et al. Clinical findings from the landmark MEF2C-related disorders natural history study. Mol Genet Genomic Med. 2022; 10: e1919.

[8] Holmes TD, Pandey RV, Helm EY, et al. The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation. Sci Immunol. 2021; 6: eabc9801.

[9] Vojdani A, Mumper E, Granpeesheh D, et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol. 2008; 205: 148-154.

[10] Yang T, Ramocki MB, Neul JL, et al. Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses. Sci Transl Med. 2012; 4:163ra158.

[11] Filiano AJ, Xu Y, Tustison NJ, et al. Unexpected role of interferon-gamma in regulating neuronal connectivity and social behaviour. Nature. 2016; 535: 425-429.

[12] Garofalo S, Cocozza G, Mormino A, et al. Natural killer cells and innate lymphoid cells 1 tune anxiety-like behavior and memory in mice via interferon-gamma and acetylcholine. Nat Commun. 2023; 14: 3103.

[13] Elman LB, Dubin RM, Kelley M, McCluskey L. Management of oropharyngeal and tracheobronchial secretions in patients with neurologic disease. J Palliat Med. 2005; 8: 1150-1159.

[14] Schumann K, Raju SS, Lauber M, Kolb S, et al. Functional CRISPR dissection of gene networks controlling human regulatory T cell identity. Nat Immunol. 2020; 21: 1456-1466.

[15] McAuley GE, Yiu G, Chang PC, et al. Human T cell generation is restored in CD3delta severe combined immunodeficiency through adenine base editing. Cell. 2023; 186: 1398-1416.

[16] Martin-Rufino JD, Castano N, Pang M, et al. Massively parallel base editing to map variant effects in human hematopoiesis. Cell. 2023; 186: 2456-2474.

[17] Schmidt R, Steinhart Z, Layeghi M, et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 2022; 375: eabj4008.

[18] Jensen TI, Mikkelsen NS, Gao Z, et al. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome Res. 2021; 31: 2120-2130.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.